Thymic involution and immune reconstitution

被引:349
作者
Lynch, Heather E. [1 ]
Goldberg, Gabrielle L. [2 ]
Chidgey, Ann [3 ]
Van den Brink, Marcel R. M. [2 ]
Boyd, Richard [3 ]
Sempowski, Gregory D. [1 ]
机构
[1] Duke Univ, Med Ctr, Human Vaccine Inst, Durham, NC 27710 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Immunol, New York, NY 10065 USA
[3] Monash Univ, MISCL, Melbourne, Vic 3800, Australia
基金
美国国家卫生研究院; 英国医学研究理事会;
关键词
BONE-MARROW-TRANSPLANTATION; STEM-CELL TRANSPLANTATION; KERATINOCYTE GROWTH-FACTOR; VERSUS-HOST-DISEASE; LEUKEMIA INHIBITORY FACTOR; RECEPTOR-DEFICIENT MICE; EPITHELIAL-CELLS; VIRUS-INFECTIONS; THYMOCYTE DEVELOPMENT; HIV-1; INFECTION;
D O I
10.1016/j.it.2009.04.003
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Chronic thymus involution associated with aging results in less efficient T-cell development and decreased emigration of naive T cells to the periphery. Thymic decline in the aged is linked to increased morbidity and mortality in a wide range of clinical settings. Negative consequences of these effects on global health make it of paramount importance to understand the mechanisms driving thymic involution and homeostatic processes across the lifespan. There is growing evidence that thymus tissue is plastic and that the involution process might be therapeutically halted or reversed. We present here progress on the exploitation of thymosuppressive and thymostimulatory pathways using factors such as keratinocyte growth factor, interleukin 7 or sex steroid ablation for therapeutic thymus restoration and peripheral immune reconstitution in adults.
引用
收藏
页码:366 / 373
页数:8
相关论文
共 84 条
[1]  
AbdulHai A, 1996, EXP HEMATOL, V24, P1416
[2]   Keratinocyte growth factor (KGF) is required for postnatal thymic regeneration [J].
Alpdogan, Ö ;
Hubbard, VM ;
Smith, OM ;
Patel, N ;
Lu, S ;
Goldberg, GL ;
Gray, DH ;
Feinman, J ;
Kochman, AA ;
Eng, JM ;
Suh, D ;
Muriglan, SJ ;
Boyd, RL ;
van den Brink, MRM .
BLOOD, 2006, 107 (06) :2453-2460
[3]   IL-7 and IL-15:: therapeutic cytokines for immunodeficiency [J].
Alpdogan, Ö ;
van den Brink, MRM .
TRENDS IN IMMUNOLOGY, 2005, 26 (01) :56-64
[4]   Administration of interleukin-7 after allogeneic bone marrow transplantation improves immune reconstitution without aggravating graft-versus-host disease [J].
Alpdogan, O ;
Schmaltz, C ;
Muriglan, SJ ;
Kappel, BJ ;
Perales, MA ;
Rotolo, JA ;
Halm, JA ;
Rich, BE ;
van den Brink, MRM .
BLOOD, 2001, 98 (07) :2256-2265
[5]   IL-7 enhances peripheral T cell reconstitution after allogeneic hematopoietic stem cell transplantation [J].
Alpdogan, Ö ;
Muriglan, SJ ;
Eng, JM ;
Willis, LM ;
Greenberg, AS ;
Kappel, B ;
van den Brink, MRM .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 112 (07) :1095-1107
[6]   IL-7 and not stem cell Factor Reverses both the increase in apoptosis and the decline in thymopoiesis seen in aged mice [J].
Andrew, D ;
Aspinall, R .
JOURNAL OF IMMUNOLOGY, 2001, 166 (03) :1524-1530
[7]   Vaccination against infectious disease following hematopoietic stem cell transplantation [J].
Avigan, D ;
Pirofski, L ;
Lazarus, HM .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2001, 7 (03) :171-183
[8]  
BARR IG, 1982, J IMMUNOL, V128, P2825
[9]  
Bolotin E, 1996, BLOOD, V88, P1887
[10]   Growth hormone accelerates immune recovery following allogeneic T-cell-depleted bone marrow transplantation in mice [J].
Chen, BJ ;
Cui, XY ;
Sempowski, GD ;
Chao, NJ .
EXPERIMENTAL HEMATOLOGY, 2003, 31 (10) :953-958